Three Patent-Pending Products · Adaptive Agentic Framework

Adaptive Agentic AI
for High-Stakes Domains

Activénse AI builds three patent-pending Adaptive Agentic AI products on a single deterministic-core, policy-orchestrated, human-governed framework — for metabolic health, cognitive rehabilitation, and conscious wellbeing. Safety is structural, not aspirational.

·
DIPP145329 · Startup India Recognised Multi-Cloud Ready · Provider-Neutral Multi-LLM Router · Provider-Neutral DPDP-Aligned · India Residency Human-in-the-Loop by Design Bootstrapped · Self-Funded
3Patent-pending products
4Patent applications
4Trademarks filed
11Microservices in prod
9,000+Ground-truth clinical observations
0Autonomous medication advice · ever
Founder

Built by a clinical co-inventor who codes the safety in

Dt. Shilpa Bhoskar — Founder & Co-Inventor

Dt. Shilpa Bhoskar

Founder · Co-Inventor on All 4 Patent Applications · Director, Activénse Holistic Solutions Pvt Ltd

Founder and co-inventor across all three AI products. Co-invented and authored the safety architecture (ADR-005 Structural Dosing Prohibition, ADR-004 Confidence-Gated Escalation, ADR-009 Deterministic-Core Agentic Framework) that powers the Activénse AI portfolio.

Clinical credentials provide the ground-truth labelling discipline behind every product: Gold Medal — MSc Dietetics & Food Service Management · MBA · Certified Nutritionist & Sports Nutritionist · NLP Practitioner · Visiting Faculty, Bharati Vidyapeeth, Pune.

"Safety in clinical AI cannot live in a prompt. It must live in the schema, the database trigger, and the policy engine. That is how we built it."
shilpabhoskar@activense.com · +91-9923218618 · LinkedIn available on request
The Portfolio

Three products. Four patent applications. Shared framework.

Each product is independently patentable and serves a distinct high-stakes domain. They share an underlying technical platform — the Adaptive Agentic Framework — which is what makes safety, audit, and policy guarantees consistent across the portfolio.

Live · 2 patents pending
Glycosutra
Adaptive Agentic AI for Pre-Diabetes Reversal

India's first patent-pending agentic AI platform for diabetes prevention. Multimodal meal capture, real-time CGM correlation, clinician-in-the-loop policy engine. Live in production with a dietitian-supervised cohort. Patent-pending Low-GI atta flour (GI 48-52, Indian Patent App. 202621040227) and patent-claimed adaptive food-substitution architecture across 621 Indian foods in 7 languages.

App 202621040877 · 27 claims App 202621040227 · Aataa flour Multimodal capture CGM correlation 621 Indian foods
Visit glycosutra.ai →
Live · 1 patent pending
Cognitrion
Adaptive Agentic AI for Aphasia & Cognitive Rehabilitation

India's first AI-powered aphasia and neuropsychological assessment platform. Built on clinical neuropsychology expertise from the University of Bristol and University of Stirling. Structured assessment, progress tracking, and personalised rehabilitation pathways for stroke and TBI patients. Safety architecture inherited from the shared framework.

App 202521091684 Aphasia Stroke rehab Neuropsychology TBI
Visit cognitrion.ai →
Sprint 0 · 1 patent pending
Sankalpa-i
A daily practice companion, grounded in Indian wisdom

A patent-pending mobile AI companion for daily contemplative practice — grounded in Indian wisdom traditions. Personalised guidance that adapts to your day and learns your patterns over weeks and months. Safety architecture inherited from the shared framework. 108 founding seekers · launching September 14, 2026.

App 202621041365 Daily practice Indian wisdom Mobile-first 108 founding seekers
Visit sankalpai.in →
The Shared Platform

The Adaptive Agentic Framework

A patent-claimed architectural framework that powers all three products. Safety, audit, and policy are designed as structural guarantees — not prompt-level instructions. The same Architecture Decision Records govern every product in the portfolio. Implementation details are patent-claimed and available under NDA.

ADR-009

Deterministic core · LLMs as components

The policy engine is the sole decision authority. Large language models are bounded components for capture and narration — never controllers. No tool-calling agents with side effects. No autonomous workflow agents. No self-directed loops.

ADR-003

Tamper-evident audit architecture

Every clinical decision recorded in a tamper-evident audit trail. Append-only at the data layer, exportable for regulatory review. Implementation details under NDA.

ADR-004

Confidence-gated human escalation

Multi-tier human escalation with confidence-gated routing. Low-confidence outputs never act autonomously — they request human review. Tier architecture and confidence-routing details under NDA.

ADR-005

Structural safety prohibitions

No endpoint, schema, model field, or UI surface in the entire codebase can express medication or insulin dosing. Enforced at the architecture level, not at the prompt level. Carries across every healthcare product in the portfolio.

ADR-010 / 011

Provider-neutral LLM router

Provider-neutral routing across multiple large language models, selected per call by task and safety profile. Multi-model safety architecture details under NDA.

Human Governance

Human-in-the-loop by design

Dietitians and clinicians are the sole approval authority for patient-facing changes. Agents are advisory only. LLMs are components, never controllers. Self-directed or goal-seeking agents are forbidden by architectural decree.

Architecture Posture
Cloud
Multi-cloud-ready · provider-neutral · DPDP-compliant Indian-residency hosting
AI Models
Provider-neutral router across multiple large language models — selected per call by task and safety profile
Data Discipline
Append-only clinical audit chain · encrypted PII · tamper-evident records · patent-claimed
Compliance
DPDP Act 2023 aligned · India residency · HIPAA-aligned controls · ISO 27001 in flight · structural dosing prohibition
Governance
Human-in-the-loop by design · clinician and dietitian sign-off on every patient-facing change · agents advisory only
Intellectual Property & Recognition

Four Indian patent applications · Coherent IP portfolio

Provisional patent applications filed with the Indian Patent Office across all three products plus the Glycosutra Aataa low-GI composite flour. Custody with Adv. Anand Mahirkar. Startup India DIPP recognition since September 2023.

Indian Patent App. No.
202621040877
Glycosutra (software)
27 claims · Filed 31 Mar 2026 · Pre-Diabetes Reversal
Indian Patent App. No.
202621040227
Glycosutra Aataa
Filed 30 Mar 2026 · Low-GI Composite Flour (GI 48–52)
Indian Patent App. No.
202521091684
Cognitrion
Filed 24 Sep 2025 · Aphasia & Cognitive Rehabilitation
Indian Patent App. No.
202621041365
Sankalpa-i
Filed 31 Mar 2026 · Hierarchical Multi-Agent AI with Multi-Modal Output
Trademarks
4
Filed
Activénse · Glycosutra · Cognitrion · Sankalpa
Startup India DIPP
145329
Recognised since Sept 2023
Department for Promotion of Industry and Internal Trade
Corporate Identity Number
U74999PN2022PTC216787
Activénse Holistic Solutions Pvt Ltd
Incorporated December 2022 · Pune, Maharashtra
Corporate Structure

How the AI portfolio fits within the parent group

We surface this structure proactively because credibility in a regulated AI product portfolio depends on clean disclosure, not concealment.

Current entity structure

  • Parent entity — Activénse Holistic Solutions Pvt Ltd · Pune, India · CIN U74999PN2022PTC216787 · Pvt Ltd incorporated December 2022 (business operating since 2013 under earlier brands). Owns the patents, signs vendor contracts, engages the team, and operates production today.
  • AI products R&D arm — Activénse AI (this portfolio, activense.ai). Three patent-pending Adaptive Agentic AI products on a shared technical framework. DIPP145329-recognised by Startup India.
  • Clinical practice — Activénse (activense.com). The 10+ year clinical-domain practice that funds the AI R&D, provides ground-truth labelling for the healthtech products, and acts as the human-in-the-loop oversight for Glycosutra and Cognitrion in production.

We welcome questions from investors, partners, and programme reviewers about how this maps onto your evaluation criteria.

Reach Activénse AI

Get in touch

For partnerships, clinical collaborations, investor enquiries, or programme reviewers.

Lead Contact

Dt. Shilpa Bhoskar shilpabhoskar@activense.com

+91-9923218618

Products

glycosutra.ai cognitrion.ai sankalpai.in

Registered Office

Activénse Holistic Solutions Pvt Ltd

CIN U74999PN2022PTC216787
Warje, Pune, Maharashtra 411052
DIPP145329